BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
| Market Capitalization | $23.6733 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.025 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.02 |
| EBITDA | -4,394.445 |
| Profit Margin | -1.7744 |
| Operating Margin TTM | -1.5803 |
| Return on Assets TTM | -0.2972 |
| Return on Equity TTM | -0.6815 |
| Revenue TTM | 2,852.694 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2017-12-31 | 241.15 | |||
| 2018-12-31 | 256.53 | |||
| 2019-12-31 | 441.59 | |||
| 2020-12-31 | 275 | |||
| 2021-12-31 | 718.67 | 3,914.511 | ||
| 2022-12-31 | 2,790.54 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2017-12-31 | 309.13 | 560.02 | 641.86 | 0 | 500 | 3,434.543 |
| 2018-12-31 | 276.64 | 540.34 | 52.14 | 0 | 0 | 4,434.543 |
| 2019-12-31 | 416.23 | 819.56 | 380.64 | 0 | 300 | 4,939.58 |
| 2020-12-31 | 3,407.61 | 4,132.46 | 525.6 | 0 | 0 | 9,456.232 |
| 2021-12-31 | 5,571.417 | 10,590.263 | 950.423 | 0 | 0 | 18,871.951 |
| 2022-12-31 | 3,174.09 | 8,371.17 | 3,157.4 | 19,281.95 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2017-12-31 | -467.632 | -470.814 | 15.07 | |||
| 2018-12-31 | -429.957 | -525.011 | -32.483 | |||
| 2019-12-31 | -696.36 | -661.651 | 139.582 | |||
| 2020-12-31 | -1,524.97 | -1,206.42 | 2,991.379 | 3,407.605 | ||
| 2021-12-31 | -3,385.493 | -3,219.32 | 2,163.812 | 3,407.605 | 5,571.417 | |
| 2022-12-31 | -5,061.755 | -6,048.09 | -2,397.32 | 5,571.416 | 3,174.092 |